Skip to content
healthcare.dev

Guanfacine

NDC 63304-924, Guanfacine, tablet, extended release, from Sun Pharmaceutical Industries, Inc.

Product NDC
63304-924
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205689
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63304-924 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUANFACINE HYDROCHLORIDE1 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
63304-924-0563304092405500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-924-05)
63304-924-306330409243030 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-924-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2d0a0f8e-5098-4ee2-a4ee-d026789923e2

Use it

Look up 63304-924 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63304-924 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63304-924. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.